Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2021/05/033605
CTRI/2021/05/033605Not yet recruiting未知

Colchicine for prophylaxis against SARS-CoV-2 infection in maintenance hemodialysis patients: a prospective, open label, randomized controlled trial - NI

CMC Fluid research Funding0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Patients with end stage kidney disease who are on maintenance hemodialysis in our institute, not meeting exclusion criteria, after written informed consent.

Exclusion Criteria

  • •1.Age < 18 years
  • •2.Not willing to enter the study
  • •3.Known hypersensitivity to colchicine
  • •4.Inflammatory bowel disease, chronic diarrhea or malabsorption
  • •5.Previous neuromuscular disease
  • •6.Cirrhosis, active chronic hepatitis or severe hepatic disease defined by SGOT or SGPT levels three times above the normal upper limit
  • •7.Treatment with immunosuppressive agents, corticosteroids or interleukin-1 antagonists for 6 months before inclusion
  • •8.Pregnant or breastfeeding females
  • •9.Patient currently taking colchicine for other indications
  • •10.Patient is considered by the investigator, for any reason, to be an unsuitable candidate for the study

Investigators

Sponsor
CMC Fluid research Funding

Similar Trials

Not yet recruiting
Not Applicable
Will treatment with a drug named colchicine be useful in treating Corona virus infection in kidney failure patients who are on regular dialysis?
CTRI/2021/05/033537CMC Fluid research Funding
Active, not recruiting
Phase 1
Chemoprophylaxis of SARS-CoV-2 infection (COVID-19) in exposed healthcare workers: a randomized double-blind placebo-controlled clinical trialHealthcare workersMedDRA version: 21.1Level: LLTClassification code 10008434Term: Chemoprophylaxis NOSSystem Organ Class: 100000004865MedDRA version: 20.0Level: LLTClassification code 10061986Term: SARSSystem Organ Class: 100000004862
EUCTR2020-001188-96-FRCHU de Saint Etienne1,200
Not yet recruiting
Phase 2
Prophylactic study of Ashwagandha and HCQ in health care providers
CTRI/2020/09/028007CSIR Ministry of Ayush
Recruiting
Phase 2
Ashwagandha for prevention against SARS-CoV-2 Infection: A Randomized Hydroxychloroquine Controlled drug trial in high risk Health Care Providers
CTRI/2020/05/025332MINISTRY OF AYUSH
Recruiting
Phase 3
Colchicine to Reduce COVID-19 Related complications in High Risk Patients Post COVID-19 Infectio
CTRI/2021/11/038234Dr Vivekanand Jha